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Background: Family carers of people living with dementia often need support with
making decisions about care. Many find end‐of‐life care decisions particularly dif-
ficult. The aim of this article is to present an evidence‐ and theoretical‐based pro-
cess for developing a decision aid to support family carers of people with dementia
towards the end‐of‐life.
Methods: Following a systematic process, we developed a decision aid using copro-
duction methods and matrices to synthesize data from a systematic review and qua-
litative interviews with people living with dementia and family carers. Data were
presented to coproduction workshops of people living with dementia, family carers,
practitioners and professionals. Development was guided by the Ottawa Decision
Support Framework and a modified Interprofessional Shared Decision‐Making model.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2021 The Authors. Health Expectations published by John Wiley & Sons Ltd.
Results: The decision aid covers four decision areas: (1) changes in care; (2) eating
and drinking difficulties; (3) everyday well‐being; and (4) healthcare, tests and
medication. We present an interactive decision aid, using a variety of approaches
including written text, Frequently Asked Questions, top tips and illustrative quotes
from people living with dementia and family carers.
Conclusion: This is the first decision aid that focusses on multiple decisions towards
the end‐of‐life in dementia care. The process offers a template for others to develop
decision aids or similar interventions, and how to include people living with de-
mentia in coproduction.
Patient or Public Contribution: Family carers provided feedback on data collection,
data analysis and the decision aid, and one is a coauthor. People living with de-
mentia and family carers were integral to the coproduction workshops.
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1 | BACKGROUND
Most people living with dementia live in the community, in their own
homes or with family.1,2 Approximately 700,000 family members and
friends are primary carers providing the majority of care for people
living with dementia in the United Kingdom.3 For the purpose of this
study, we used the term family carer to describe family and friends
providing unpaid care for someone living with dementia, acknowl-
edging that they may not identify themselves as a carer.4,5
Shared decision‐making is an important part of healthcare and
person‐centred dementia care.6 However, as an individual's de-
mentia progresses, he or she becomes less likely to be able to make
decisions about his or her care, well‐being and general welfare. Ad-
vance care planning (ACP) is a process of planning for care in the
future. Studies have demonstrated the effectiveness of ACP on
several outcomes including family satisfaction with care and bur-
densome transitions in care.7,8 However, many individuals reach the
point when they no longer have capacity to make their own deci-
sions. In England and Wales, under the Mental Capacity Act (MCA)
2005, decisions for those who lack capacity should be made in their
best interests if there is no prior legal authority.9 Decision‐makers
will vary and are usually made through a family carer or a health or
care professional depending on the significance of the decision to be
made and national legislation; however, a shared decision‐making
approach should be encouraged.
Family carers find decisions or discussions about severe de-
mentia and end‐of‐life difficult, such as stopping treatment,10–12 and
they may benefit from support in making decisions.13–15 Help may be
welcomed by carers making significant decisions, especially about
support when their family member is in the severe stages of de-
mentia and towards the end‐of‐life.16,17 A recent ACP intervention in
nursing homes has been shown to be effective in reducing family
carer uncertainty with decision‐making, and improving perceptions
of quality of care.18 However, this approach includes a facilitator and
is based in nursing homes, where there may be more support to
complete ACP than for carers at home with the person living with
dementia. It has been recognized that alternative approaches to
decision‐making are required across different settings.7
Another approach to support family carers is decision aids,
which guide the decision‐maker through different stages of a deci-
sion. These can take various forms including booklets, pamphlets,
videos or web‐based tools. Decision aids provide information about
the decision and summarize options along with associated benefits
and harms to enable people to make and document decisions.19
There is substantial evidence from the health sector demonstrating
the effectiveness and feasibility of decision aids to support decision‐
making.19,20
The clarity about the options that decision aids offer may be
particularly useful for family carers of people living with severe de-
mentia or those approaching the end‐of‐life. Such times often involve
a variety of symptoms and comorbidities, potentially creating con-
fusion and a multitude of difficult decisions for the family carer.21
Decision aids suitable for use by family carers in dementia care
have been shown to improve knowledge and communication, and
reduce decisional conflict among family carers.16,22 However, these
decision aids only focus on a single decision, including eating and
feeding options,23 place of care24,25 and goals of care.26,27 When
caring for someone living with dementia towards the end‐of‐life,
family carers are often faced with multiple decisions, and these are
often inter‐related. There is currently no decision aid for dementia
care that covers multiple decisions. There is a need for holistic de-
cision aids to reflect this complexity.16 In particular, studies have
identified a need for decision aids that focus on those with dementia
towards the end‐of‐life.16,17
It is important that end users (family carers), together with those
who the decision aid affects (people living with dementia) and those
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who will interact with carers using the decision aid (practitioners and
carer organizations/advocates), are involved in development. How-
ever, reviews of patient decision aids have highlighted a lack of clear
reporting about the development process of decision aids.16,28
This article reports the systematic development and components of
a decision aid for family carers of a person living with dementia towards
the end‐of‐life. This builds on a programme of work that included a
systematic review of evidence for effectiveness of existing decision
aids,16 and a qualitative study with family carers of people with dementia
towards the end‐of‐life and people living with dementia themselves.29
The aim of this article is to present an evidence‐ and theoretical‐
based process for developing a decision aid to support family carers
of people with dementia towards the end‐of‐life.
2 | METHODS
2.1 | Design
A coproduction approach was adopted to develop a decision aid, as
part of a systematic development process for decision aids.28,30
Coproduction is increasingly being used in healthcare research
and for the development of resources used in clinical practice, in-
cluding in dementia research.31–33 Partnership with stakeholders and
end users has been identified as a fundamental approach of inter-
vention development and this is the core premise of coproduction.34
The use of coproduction is particularly recommended for use in the
development of patient decision aids.35
We were informed by a review of developing complex inter-
ventions,34 which provides a comprehensive range of approaches
and actions to develop complex interventions. Actions are described
across the domains of conception, planning, designing, creating, re-
fining, documenting and planning for future evaluation.
2.2 | Theoretical frameworks underpinning
development
The development of content for the decision aid was guided by two
theories: (1) the Ottawa Decision Support Framework (ODSF)36 and
(2) a modified version of the InterProfessional–Shared Decision
Making (IP‐SDM) Model.37
2.2.1 | ODSF
The ODSF was developed to help facilitate shared decision‐making
between patients and healthcare professionals.24,36 Decision aids
developed using the ODSF have been shown to be effective in re-
ducing decisional conflict and improving decisional quality.20 We
chose this framework as it supports health decisions that lack clear
choice, are value laden, require much deliberation and are subject to
changing circumstances.36 This resonates with the decisions that
carers of people with dementia encounter. The aim of the ODSF is to
improve the quality of decision‐making by addressing modifiable and
suboptimal determinants of decisions, including unrealistic expecta-
tions, unclear views, unclear norms, unwanted pressure, inadequate
support and inadequate personal and external resources to make the
decision. ODSF is organized into (1) decisional needs, (2) decision
support and (3) decision quality (see Table 5). It states that the de-
cisional needs will affect the quality of the decision, and this can be
mediated by decision support such as a decision aid.
2.2.2 | The IP‐SDM model
The IP‐SDM model has been widely used to inform development of
decision aids;38 it conceptualizes the decision‐making process and the
factors that influence this.37 We used a modified model based on the
dementia population, who lack capacity, and the specific decisions fa-
cing family carers.29 The model consists of two sections: the context in
which decisions are made and the decision‐making process. The context
considers personal preferences, ACP and legal aspects of decision‐
making, health and well‐being of the individual (including capacity),
support from others and clarity of decision‐maker roles. The process
consists of (1) identifying the decision‐maker or team, (2) sharing and
exchanging information, (3) clarifying values and preferences, (4)
managing and considering emotions, (5) considering the feasibility of
options, (6) balancing the preferred choice and the actual choice, and (7)
implementation and reflecting on outcomes.
2.2.3 | International patient decision aid standards
We report the content and development of the decision aid against
the International Patient Decision Aid collaboration set of Standards
and criteria (IPDASi v 4.0) for decision aids39 (see appendix).
2.3 | Ethics statement
This study received ethical approval from the London Queen Square
Research Ethics Committee (18/LO/0408), and all participants pro-
vided written informed consent.
2.4 | Participants and recruitment
2.4.1 | Family carers and people living with
dementia
Eight family carers of people living with dementia who identified as
caring for someone towards the end‐of‐life, and four people with
mild dementia were purposively sampled.
Family carers and people with dementia were recruited via
clinical services including National Health Service (NHS) memory
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clinics and general practices in Greater London, UK. Invitations were
sent by the recruiting organization, and clinical teams reviewed the
eligibility criteria before inviting participants. Interested participants
were asked to contact the research team directly. Recruitment was
supplemented from local and national dementia organizations, Na-
tional Institute for Health Research (NIHR) Join Dementia Research
(online network) and participants from earlier phases of the project.
2.4.2 | Practitioners
Eleven practitioners who provided care for people with dementia
towards the end‐of‐life and from carer support organizations were
recruited through contacts of the research team and supplemented
with snowballing methods. Participants were purposively sampled
for a variety of occupations.
2.5 | Inclusion and exclusion criteria
All participants had to be able to read and speak English and provide
informed written consent.
2.5.1 | Family Carers
Inclusion criteria
• Family member or friend who provided unpaid care for a person
living with dementia in the later stages of dementia or towards
the end‐of‐life.
• Current or former carer.
• Proxy decision‐maker for the person living with dementia, either
informally or through lasting power of attorney for health and
welfare.
• Over the age of 18 years.
Exclusion criteria
• Carers bereaved in the past 3 months.
2.5.2 | People with dementia
Inclusion criteria
• Clinical diagnosis of any type of dementia.
• Mental capacity to provide informed consent.
• Over the age of 65 years.
2.5.3 | Practitioners from health and care services
and carer organisations
Inclusion criteria
One or more of the following:
• Practitioners in a caring role (health or social care), for someone
with dementia.
• Experienced in providing end‐of‐life care and contributing to
decision‐making dementia or family carers.
• Experienced in working directly with people living with dementia
or family carers.
2.6 | Procedure
An experts by experience group consisting of four family carers
oversaw the whole project, commenting on study documents, pro-
cedures and findings. An overview of the process and procedure is
provided in Figure 1.
2.6.1 | Earlier phases of the overall project
The systematic review16 and qualitative data collection29 in earlier
parts of the project allowed us to complete the following actions
from O'Cathain et al.'s taxonomy34:
Previous work – systematic review 
and qualitative interviews
Step 3: Refining the decision aid 
through our think tank
Step 2: Designing and creating
Step 1: Planning and synthesis of 
data
Step 4: Refining the decision aid 
through user testing
F IGURE 1 Overview of the development process
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• understand the problems or issues (decisions) to be addressed;
• understand the experiences of family carers and people living with
dementia about decision‐making;
• understand the perspectives and the psycho‐social context of fa-
mily carers making decisions;
• understand the wider context of decision‐making in de-
mentia care;
• consider where the decision aid will be implemented; and
• identify evidence of the effectiveness of similar interventions.
The qualitative data highlighted the key decisions to be made and
the factors to consider in the decision‐making process. Key decisions
included (1) transitions in care; (2) medical care or clinical interven-
tions, and physical well‐being; (3) eating and drinking; (4) psychologi-
cal/emotional well‐being; (5) distress of the individual (including
emotional well‐being); (6) communication; and (7) conflict/disagree-
ment with others about providing care and decisions. There were
multiple factors that needed to be considered when making decisions
including personal preferences, the emotional experience of decision‐
making, the health and well‐being of the person living with dementia,
professional input and support. Finally, these data were used to revise
the IP‐SDM model and provide the seven steps of the decision‐making
process detailed in the IP‐SDM section above.29
The systematic review helped to identify existing decision aids to
share with the coproduction groups, understand what components
were included in previous decision aids and which decision aids were
effective.16 The review concluded that decision aids developed thus
far have focussed on single decisions. Further decision aids are re-
quired that reflect the complexity of dementia care with multiple
decisions to be made by family carers, which are often inter‐related.
Coproduction was divided into four main steps:
Step 1: Planning and synthesis of data.
To synthesize the findings from the qualitative data and sys-
tematic review, we constructed a series of matrices to allow a
transparent and thorough mapping of the different sources of data.
This process was iterative and on‐going, before and during the co-
production workshops, and when refining the decision aid. After each
workshop, key points were summarized in Table 1. This provided a
clear overview of the potential topics and decisions to be included in
the decision aid.
Step 2: Designing and creating.
We constructed a series of coproduction groups to meet in
workshops.
2.6.2 | Aim of workshops
Based on O'Cathain et al.'s taxonomy,34 the aims of the workshops
were to understand wider stakeholders' perspectives of the deci-
sions and issues, decide upon the specific decisions that the decision
aid should address, and the aims or goals for the decision aid; con-
sider real‐world delivery of the decision aid; decide on the content,
format and delivery; and make prototypes of the decision aid.
2.6.3 | Composition of the workshops
We created four homogeneous coproduction groups: people living
with mild dementia, family carers and two groups of professionals
from health and social care services (see Tables 2–4).
2.6.4 | Including people living with dementia in
coproduction workshops
We worked closely with our experts by experience group and
practitioners working in dementia care to carefully consider how to
optimally run a workshop with people living with dementia. We en-
sured that this workshop consisted of a small number of participants
(e.g., 3–5), to minimize distractions and confusion. We wanted to
ensure a feeling of being in a safe environment and of feeling com-
fortable throughout, developing trust and a rapport with re-
searchers.40 To establish this trust and safe environment, we offered
the option of bringing a person with them such as a family carer.
However, to ensure that the contributions of people living with de-
mentia were heard, we asked, if possible, that the other person might
sit in an adjacent room. As most participants had taken part in the
qualitative phase of the study, at least one of the researchers was
familiar to them. We also held a preworkshop telephone discussion
to provide information about the study and build on the rapport and
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relationship with the participant. At the start of the workshop, we
spent time talking and ‘mingling' over refreshments to create a calm
and relaxed atmosphere.
We provided accessible (large print and plain English) printed
worksheets and information to support participants living with de-
mentia. We ensured that a third researcher was available to sit with
the carers who attended. Participants were also given the option to
use a printed coloured card that read ‘I wish to speak' to hold up if
they were not able to speak out or felt that they could not be heard.
Finally, we provided breaks during the workshop and ensured that
the timing was flexible to meet individuals' needs, following others'
recommendations.31,41
2.6.5 | Workshops' structure and contents
Each group met once for 1.5 h over several months as workshops
facilitated by two or three researchers (N. D., T. D. S.). We used a
modified nominal group process,32,42,43 which includes using struc-
tured meetings to solve specific problems, facilitate group thinking
and decision‐making. Participants were presented with short inputs
on background, reviews of literature and evidence from the quali-
tative interviews through PowerPoint presentations that were based
on the matrices. We used a combination of approaches and stages to
encourage discussion and generate ideas (see Box 1). Detailed notes
were made throughout the discussion, and participants provided
additional feedback via email. At the end of each workshop, the re-
search team agreed with the group on the key points to inform the
next iteration of the decision aid.
We used the IP‐SDM model to shape our discussions in the
workshops on the format of the decision aid. For example, we asked
participants how to present in the decision aid an opportunity to
reflect on the wishes, preferences and values of the person with
dementia when making decisions.
In the first workshop with carers, we provided and discussed
examples of decision aids identified from our systematic review. In
the other three workshops with the two professional groups and
with people living with dementia, we showed participants the de-
veloping prototype of our decision aid. This group order ensured that
TABLE 2 Practitioners from health and care services and carer
organizations
Role N
End‐of‐life care facilitator 1




Social care professional 1
Palliative care nurse 1
Health editor 1
Clinical educator–palliative care 1




TABLE 3 Family carer demographics
N














TABLE 4 People with dementia demographics
N
Type of dementia
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the core topics and contents of the decision aid were grounded in the
views of family carers and people living with dementia, placing
greater emphasis on these groups as the ultimate end users. Pro-
fessional groups helped us to flesh out the content including clinical
details and advice to add to the decision aid.
Step 3: Refining the decision aid through our think tank.
In parallel to Step 2, Step 3 focussed on refining and finalizing
the decision aid. A fifth group acting as a ‘think tank' to support
coproduction was created. This group consisted of two family carers,
a General Practitioner (GP), an Admiral Nurse (specialist dementia
nurse that support families), two gerontologists and a social work
expert. The research team also joined this group, consisting of two
psychologists, a GP and an Old Age Psychiatrist. The detailed notes
were summarized and presented to the group. In particular, the
group:
• provided clarity about ideas and discussions from coproduction
workshops;
• ensured that the research team considered the views from all
three coproduction groups; and
• ensured that the decision aid was grounded in evidence.
The fifth group met three times for 1–2 h, in between the
workshops.
Step 4: Refining and user testing.
Once the decision aid was finalized by the ‘think tank,' it was
tested with the experts by the experience group and two carers from
the coproduction workshop. They read through the decision aid with
one individual researcher, and using the principles of the think aloud
method,44 provided their initial impressions of the format and con-
tent of the decision aid.
The results from the user testing were discussed among the core
research team (N.D., G.R., E.L.S.), and comments were incorporated.
3 | FINDINGS
3.1 | Overview of the decision aid
The decision aid opens with an introductory section about dementia,
end‐of‐life care and considering the context of the decision‐maker,
including clarifying what their role is, and what is important to them.
Subsequently, carers record their social network, including who they
see on a daily basis, and record this on a social network diagram (see
Figure 2).
Participants at all workshops considered that it was important to
highlight who was responsible for making decisions, and to empha-
size that decisions were not necessarily the family carers' to make, in
Box 1. Stages of workshops
Stage 1: Welcome and overview of project, overview for
workshop, aims of this group and ground rules.
Stage 2: Presentation and discussion of example decision
aids (Carers workshop only).
Stage 3: Key findings from the qualitative study (presented
as 10 key decisions and factors influencing decisions).
Stage 4: Discussion of each decision facilitated by key
questions.
Stage 5: Rank priority of decisions.
Stage 6: Presentation and discussion about developing the
prototype.
Stage 7: Summary of discussion and close.
F IGURE 2 Identifying carers' support networks
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particular, decisions about medical care and treatment. To highlight
this, the decision aid includes information on ‘best interests' deci-
sions, asks the carer if they have Lasting Power of Attorney and
encourages discussions with health and social care teams through-
out. A further section discusses the importance of looking after
themselves as carers, and advice about staying well.
3.2 | Decisions
The workshops were presented with seven decisions from the qua-
litative data. After the initial discussion, workshops ranked the de-
cisions based on importance and relevance to include in the decision
aid. This helped to consider decisions in turn to inform subsequent
discussions. Carers in the workshops were not surprised by any of
the decisions that we presented.
The decision regarding conflict/disagreement with others, fol-
lowed by communication, and eating and drinking received the
lowest scores across all workshops. Discussion within the workshops
revealed that communication and conflict were more contextual
factors that influence all decisions. However, managing eating and
drinking were considered a decision that was important to include
despite its low ranking, across all groups. Conflict and communica-
tion were removed as decision topics, but were added as background
information sections.
During a meeting with the ‘think tank', researchers fed back on
the discussions and ranking from the workshops. Four decisions were
chosen as the final decisions to include in the decision aid:
1. Changes in care.
The qualitative data highlighted the challenges to family car-
ers of transitions in care, including moving into a care home,
hospital admissions and changes in the level of home care. The
systematic review had found decision aids developed for deci-
sions about care home moves, but little on other aspects of care
transitions and home care. Evidence from the interviews and
systematic review was presented to the coproduction groups. All
agreed that this was one of the most important and common
decisions. Carer and professional coproduction groups high-
lighted the need to include information for both carers who were
self‐funded and state funded. Carers were also keen to highlight
the need to consider what they as carers could manage and re-
cognize their preferences.
2. Eating and drinking difficulties.
Decision aids covering eating and drinking were identified in
the systematic review; however, they focussed on artificial nu-
trition and hydration. Qualitative data from family carer inter-
views showed that they felt ill equipped and under‐informed
more broadly about eating and drinking. This included under-
standing the progression of dementia and its impact on eating and
drinking, and the importance of a healthy diet. In the coproduc-
tion workshops, professionals viewed this as more of a challen-
ging area than carers; however, many carers may not have
encountered such problems. The decision aid provides ‘myth
busters' about eating and drinking, including tips on how to
manage this, such as how to encourage eating. Carefully worded
information is provided to explain that people eat less towards
the end‐of‐life and it is not important to encourage a healthy diet,
but rather food they find enjoyable.
3. Everyday well‐being for the person with dementia.
Ensuring the health and well‐being of the individual was a
prominent theme in the qualitative data. This encompassed not
only increasing physical needs as the individual's dementia pro-
gressed but also their emotional well‐being. Originally two se-
parate decisions, the carer coproduction group felt that physical
well‐being and psychological/emotional well‐being could be en-
capsulated as everyday well‐being for the person living with de-
mentia in the decision aid. Carers from workshops were keen to
highlight continence as a specific challenge. Professionals em-
phasized that continence was often the key ‘tipping point' for
many carers to stop continuing to provide care at home. Other
aspects included sleep and distress.
4. Healthcare, tests and medication.
The systematic review identified decision aids focussed on goals
of care, and qualitative data described the various tests and treat-
ments that participants did not want or felt needed to be carefully
considered if they were approaching death. The coproduction groups
with people living with dementia and professionals were keen for the
section to highlight that many of these decisions are not just the
carers' responsibility, but should be a shared decision‐making ap-
proach with the healthcare team. A summary table of medications is
provided for carers to complete with the healthcare team to en-
courage discussion and de‐prescribing as necessary (see Appendix).
3.3 | Format and engagement
Directed by the seven stages of the adapted IP‐SDM model, we
broke down the decision‐making process for each of the four deci-
sions. Throughout these seven stages, we carefully followed the
ODSF to inform the content. Tables 5 and 6 provide an overview of
how we operationalized the ODSF and IP‐SDM models by using a
variety of components in the decision aid.
Engagement with both the person living with dementia and fa-
mily carer was a key consideration throughout our coproduction and
supported by our adapted IP‐SDM model. The carers group thought
that it was vital that there was space in each of the decisions to
reflect on the consequences and outcomes of each decision. The
resulting decision aid is presented as an interactive booklet to en-
gage carers. To encourage engagement, the decision aid poses
questions to carers throughout. Carers record their answers and
preferences. Information is provided via a variety of formats in-
cluding written text, frequently asked questions (FAQs), top tips and
illustrative quotes from people living with dementia and family car-
ers. We provide myth busters as recommended by professionals and
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supported by family carers and people with dementia in our copro-
duction groups (see Figure 3). These formats were seen as a way to
engage the reader while demonstrating the key principles of a de-
cision aid as defined in the IPDASi v4.0 including describing the
options available, the benefits and advantages of options and ex-
periences of the consequences of the options (e.g., physical, psy-
chosocial and social).
Based on family carer suggestions, we included individual stories
or broad scenarios from people who have experienced similar si-
tuations, with information about how they came to their decision and
the outcomes. Participants felt that carers would relate more to a
story than just facts. This approach was used for discussing con-
tinence, an often embarrassing topic.
Following suggestions from the professionals workshop, we in-
cluded the benefits and disadvantages of options using an activity
asking carers to list all the reasons why they would choose the option
(i.e., benefits) and reasons why not to choose this option (i.e., dis-
advantages) on a set of blank paper cards provided with the decision
aid. These cards can then be stacked into two piles to help
visualize which options/preferences have the most benefits and
disadvantages.
Finally, carers are asked if they have enough information and, if
yes, which preference or option they prefer, recording their decision.
If they do not have enough information to make a decision, the final
section for each decision provides both (1) signposting to specific
groups and organizations and (2) a space to write questions to dis-
cuss with a health or care provider. Throughout the decision aid,
carers are encouraged to discuss options and decisions with other
members of their support network, including health and social care
professionals, ensuring a shared decision‐making approach.
4 | DISCUSSION
This article presents a novel decision aid to support family carers of
people living with dementia towards the end‐of‐life. This is the first
decision aid to cover multiple decisions that family carers may face
when a person living with dementia is approaching the end‐of‐life,
filling an important gap identified in the decision‐making litera-
ture.7,16,22 This is one of the first papers to provide a detailed de-
scription of a systematic approach to coproducing a decision aid,
grounded in theory, evidence and lived experience. There is in-
creasing recognition of the importance of high‐quality reporting of
coproduction methods and the development process of decision
aids.45–47 Few decision aids developed in dementia care report their
development clearly.16 We have provided clarity on how data from
multiple sources including theory can be synthesized and presented
to end users and meaningfully contribute to coproduction. This
transparent method will be helpful to researchers developing com-
plex interventions through coproduction. Importantly, this study is
one of the first to include people living with dementia in coproduc-
tion, and we provide key learning points.
Family carers have reported feeling ill‐prepared for decisions
about end‐of‐life care and a lack of professional support.48 The
course of dementia is unpredictable, and goals of care and pre-
ferences may change over time49; therefore, it is important to ac-
knowledge the complexities of decision‐making and the need for
carers to be adequately supported. Decisions will need to be re-
visited and may change over time50; our decision aid encourages
carers to revisit decisions and to discuss with professionals and other
family members, which can enhance decision‐making.51 Importantly,
the decision aid highlights that decisions are not just the carer's











Introductory information X X X
List of options X
Benefits and disadvantages X X
Myth busters X
Top tips X X
FAQ X
Questions for GP X X
Charting medication X




Quotes from others X
Detailing support network X
Abbreviations: FAQ, frequently asked question; GP, General Practitioner; ODSF, Ottawa Decision Support Framework.


























































































































































































































































































































































































































































































10 | DAVIES ET AL.
responsibility, but should be part of a shared decision‐making ap-
proach with the care team.52
The decision aid is an interactive booklet using multiple ap-
proaches to engage participants and encourage reflection, moving
beyond simple provision of information. The decision aid focusses on
support across changes in care, eating and drinking difficulties, ev-
eryday well‐being in dementia and healthcare tests and medication.
It was important that we provided information and options across
these decisions in a balanced and neutral manner,53 providing
evidence‐based information.
One of the unique features of the development of this decision
aid was the inclusion of people living with dementia in the design of
the intervention. In the methods, we have highlighted our approach
to ensuring that they were adequately supported to participate.
Previous work has developed alternative methods to increase the
inclusivity and engagement of people in coproduction,46 but con-
sidering this in the context of living with dementia is important.
There are increasing numbers of articles reporting on the inclusion of
people with dementia in research; however, they lack detail on co-
production methods.54 Importantly, we consider that some of the
key lessons from our experience include ensuring people living with
dementia feel comfortable, acknowledged in the research procedures
and have the time to contribute meaningfully. These can be achieved
through minor modifications to research procedures including hold-
ing smaller groups, reducing the number of tasks in workshops, in-
creasing the number of researchers to provide support (this may
need to be one to one), considering the cognitive load of tasks and
using accessible documents including consent and information
sheets.
We prepared tasks for participants to rank the priority of deci-
sions to be included. This was well received by family carers, al-
though many felt that some were equally important. Professionals
felt that many of the topics were not isolated decisions and they
were difficult to rank. This reflects the clinical reality of having to
consider multiple challenges rather than a clear ranked list of prio-
rities. People living with dementia found this task demanding. We
provided one‐on‐one support for this task, but they continued to
struggle, and on reflection, this was a cognitively demanding task
that we would not recommend for future workshops with people
living with dementia. Tasks that involved visual representations
proved much easier, including providing participants with an example
of our prototype decision aid.
4.1 | Implications for research
Research needs to further explore optimal methods and approaches
for including people living with dementia in decision‐making research
and end‐of‐life research.
Our article provides an example of how a matrix approach can
be used to synthesize findings and for intervention development.
This is a vital step that is missing in guidance on developing complex
interventions.28,55 It is an iterative approach that provides trans-
parency and clarity.
The decision aid developed will be tested in a feasibility study
exploring optimal methods of evaluation and considering accept-
ability. We will continue to work with end users and stakeholders in
the evaluation, which is vital to support implementation in routine
care and practice.56 Finally, it is also important to consider in future
research the inclusion of those who do not speak English; this will
allow us to tailor the decision aid to these populations.
4.2 | Implications for policy and clinical practice
This decision aid has many potential benefits for family carers,
people living with dementia and health and social care practitioners.
The aid could be distributed by GPs in consultations with family
carers, for example, supporting shared decision‐making, which is a
priority for the NHS Long Term Plan.57 For carers, the decision aid
may help to clarify decisions, the options available and the decision‐
making process, reducing decisional conflict, feelings of guilt and
potentially help prepare them for their relative's end‐of‐life. Despite
the decision aid being developed for family carers towards end‐of‐
life, it may be beneficial for people living with dementia to use
for ACP.
F IGURE 3 Myth busters examples from the
eating and drinking decision section
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4.3 | Strengths and limitations
We used a systematic approach following the principles of an
evidence‐based process for developing decision aids.28 To supple-
ment the gaps in guidance about specific approaches to design of
complex interventions, we used a taxonomy of evidence‐based
approaches from O'Cathain and colleagues.34
Our decision aid is strengthened by the theoretical foundations,
using the IP‐SDM model modified for dementia care decisions and
the ODSF.24,36 These enabled us to break down complex decisions
and provide a clear pathway for carers using the decision aid. Fur-
thermore, this was supplemented by experts from across clinical and
academic fields, but most importantly, included people living with
dementia and family carers in the design process.
The matrix‐based approach for synthesis offered a transparent
and systematic approach to synthesis, ensuring that the development
was rigorous and evidence based.
Due to the size of coproduction workshops, we were unable to
include all professional roles that may have been relevant. For ex-
ample, the inclusion of pharmacists, speech and language therapists
and dieticians would have been beneficial and should be targeted in
future research. Furthermore, we were not able to include people
who did not speak English; therefore, we may have missed some
important cultural variations and factors that need to be considered
when making decisions with those who do not speak English.
5 | CONCLUSION
This article presents the first decision aid that focusses on multiple
decisions towards the end‐of‐life for people living with dementia. We
provide a detailed overview of the systematic development process
of a decision aid for family carers of people living with dementia. The
process offers a template for others to develop decision aids or si-
milar decision‐making interventions, and how to include people living
with dementia in coproduction.
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APPENDIX A: Medication charting
Make a list of their medications. Discuss the list with their GP
or pharmacist. Consider do they still need this medication?
Some medications they are taking may no longer be needed or
helpful.
You can use the questions in this table as a basis for your dis-
cussion and complete together.
Medication Purpose
How often do they
take it?
When was it prescribed
or reviewed? (should be






Example: Memantine Dementia medication Daily 01.02.2019 Headaches Yes
APPENDIX B: IPDASi v4.0 checklist 32
Item Included
Qualifying criteria
Describes health condition or problem X
Explicitly states the decision that needs to be considered X
Describes the options available X
Describes the positive features (benefits/advantages) of each option X
Describes the negative features (harms, side effects or disadvantages) of each option X
Describes what it is like to experience the consequences of the options (physical, psychological, social) X
Certification criteria
Shows the negative and positive features of options in equal detail X
Provides citations to the evidence selected X
Provides a publication date X
Provides an update policy
Provides information about the levels of uncertainty around event or outcome probabilities
Provides information about the funding source used for development X
Describes what the test is designed to measure N/A
Describes the next steps typically taken if the test detects the condition N/A
Describes the next steps if the condition is not detected N/A




The patient decision aid describes the natural course of the health condition or problem, if no action is taken X
The patient decision aid makes it possible to compare the positive and negative features of the available options X
The patient decision aid provides information about outcome probabilities associated with the options (i.e., the likely consequences of
decisions).
X
The patient decision aid specifies the defined group (reference class) of patients for whom the outcome probabilities apply.
The patient decision aid specifies the event rates for the outcome probabilities
The patient decision aid allows the user to compare outcome probabilities across options using the same time period (when feasible).
The patient decision aid allows the user to compare outcome probabilities across options using the same denominator (when feasible).
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Item Included
The patient decision aid provides more than 1 way of viewing the probabilities (e.g., words, numbers and diagrams). X
The patient decision aid asks patients to think about which positive and negative features of the options matter most to them (implicitly or
explicitly).
X
The patient decision aid provides a step‐by step way to make a decision. X
The patient decision aid includes tools like worksheets or lists of questions to use when discussing options with a practitioner. X
The development process included a needs assessment with clients or patients. X
The development process included a needs assessment with health professionals. X
The development process included review by clients/patients not involved in producing the decision support intervention. X
The development process included review by professionals not involved in producing the decision support intervention. X
The patient decision aid was field tested with patients who were facing the decision.
The patient decision aid was field tested with practitioners who counsel patients who face the decision.
The patient decision aid (or associated documentation) describes how research evidence was selected or synthesized. X
The patient decision aid (or associated documentation) describes the quality of the research evidence used.
The patient decision aid includes authors'/developers' credentials or qualifications. X
The patient decision aid (or associated documentation) reports readability levels.
There is evidence that the patient decision aid improves the match between the preferences of the informed patient and the option that is
chosen.
N/A
There is evidence that the patient decision aid helps patients improve their knowledge about options' features. N/A
The patient decision aid includes information about the chances of having a true‐positive test result. N/A
The patient decision aid includes information about the chances of having a true‐negative test result. N/A
The patient decision aid includes information about the chances of having a false‐positive test result. N/A
The patient decision aid includes information about the chances of having a false‐negative test result. N/A
The patient decision aid describes the chances that the disease is detected with and without the use of the test. N/A
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